Harvard Intensive Review of Nephrology 2026 – Videos + Subtitles + PDF Slides

Harvard Intensive Review of Nephrology 2026 is a comprehensive clinical update and ABIM Nephrology Board Review covering glomerulonephritis, CKD, AKI, dialysis, transplantation, electrolytes, acid-base disorders, hypertension, genetic kidney disease, onconephrology, renal pathology, ultrasound, AI in nephrology, and more.

Demo Video :

Package includes course videos + subtitles + PDF presentation slides.

Description

+ Include: Videos + Subtitles + PDF Slides
+ Course: Harvard Intensive Review of Nephrology 2026
+ Date: August 10–14, 2026
+ Format: Online / On-Demand Course Materials
+ Target Audience: Nephrologists, Internal Medicine Physicians, Nephrology Fellows, Residents, Physicians Preparing for the ABIM Nephrology Board Examination
+ Sample Video: Contact me for sample video

Information

The Harvard Intensive Review of Nephrology 2026 is a comprehensive clinical update and nephrology board review program featuring leading clinical faculty from Harvard Medical School.

This intensive educational program provides an in-depth review of the current state of the art across all major areas of nephrology. With 70+ lectures, clinical case discussions, board preparation sessions, Q&A sessions, and supplementary presentations, the course is designed both for practicing clinicians seeking a comprehensive nephrology update and physicians preparing for the ABIM Nephrology Board Certification or Recertification Examination.

This Package Includes

• Course Videos
• Subtitles
• PDF Presentation Slides

The program covers major areas including glomerulonephritis, chronic kidney disease, acute kidney injury, electrolyte and acid-base disorders, hypertension, genetic kidney disease, dialysis, transplantation, onconephrology, renal pathology, diabetic kidney disease, pregnancy and renal disease, point-of-care renal ultrasound, and nephrology board review.

Why Choose Harvard Intensive Review of Nephrology 2026?

The 2026 program incorporates important developments and emerging areas in modern nephrology, including:

• Genetic testing for improved diagnosis, prognosis, and therapy selection
• Point-of-care ultrasound and optimal renal image acquisition
• Physical examination of dialysis access
• High-dose hemodiafiltration versus high-flux hemodialysis in ESKD
• Expanded roles of SGLT2 inhibitors, GLP-1 agonists, and finerenone
• Novel immunosuppressive therapies for glomerulonephritis
• Emerging role of CAR-T therapy
• Xenotransplantation
• Kidney-dedicated palliative care and conservative kidney management
• Artificial intelligence in nephrology

Comprehensive Nephrology Review

GLOMERULONEPHRITIS

• Basic concepts of pathology and pathophysiology
• Interpretation of the urinary sediment
• The latest treatment strategies and guidelines for:
  • Rapidly progressive glomerulonephritis
  • Lupus nephritis
  • IgA nephropathy
  • Membranous nephropathy
  • Minimal change disease
  • C3 glomerulonephritis

CHRONIC KIDNEY DISEASE

• Epidemiology of chronic kidney disease
• Best practices in the management of CKD patients
• Current approaches to the care of patients with diabetic kidney disease
• Updated approach to geriatric nephrology
• New drug therapies for management of CKD

GENETIC KIDNEY DISEASE

• State-of-the-art approaches to genetic diseases of the kidney
• Practical guide to use of renal panel genetic testing
• Latest updates on polycystic kidney disease

ACUTE KIDNEY INJURY

• Workup and management of AKI
• Biomarkers of AKI
• Current guidelines for renal replacement therapy in the ICU including CVVH and intermittent HD
• Thrombotic microangiopathies
• Cardiorenal and hepatorenal syndromes

VASCULAR DISEASE

• Hypertension for the nephrologist
• Latest guidelines for diagnosis and management of primary and secondary hypertension
• Current approach to renovascular disease

ELECTROLYTES AND ACID-BASE

• Interpretation of acid-base cases
• Fundamentals for diagnosis and management of electrolyte disorders

END-STAGE RENAL DISEASE

• Hemodialysis updates
• Peritoneal dialysis updates
• Dialysis vascular access
• Management of anemia in CKD
• Management of mineral and bone disease in advanced CKD

TRANSPLANTATION

• State-of-the-art approach to interpret tissue typing data pre- and post-transplant
• Current guidelines on using induction and maintenance immunosuppressive therapies
• Best practices in treating acute and chronic allograft rejection
• Approach to late allograft loss
• Updated strategies and guidelines in donor and recipient evaluation
• The latest treatment strategies and guidelines of common infections post-transplant

TAILORING TREATMENT FOR SPECIAL POPULATIONS

• Cancer and the kidney
• Pregnancy and renal disease
• Pediatric nephrology for the adult nephrologist
• Mesoamerican nephropathy
• Pathophysiology and treatment of diabetic kidney disease
• Racial disparities in nephrology

Course Topics / Program

Day 1 – Monday, August 10, 2026

• Welcome Remarks/Announcements — Course Directors
• Renal Physiology for the Boards — Melanie Hoenig, MD
• Basic Concepts of Immunology in Autoimmune Kidney Disease — Ramon Bonegio, MD
• Faculty Q&A — Melanie Hoenig, MD & Ramon Bonegio, MD
• Renal Pathology in 2026: Part 1 — Helmut Rennke, MD
• Renal Pathology in 2026: Part 2 — Astrid Weins, MD
• Current Approaches to Urine Sediment Analysis — Martina McGrath, MD
• Faculty Q&A — Astrid Weins, MD, Martina McGrath, MD & Helmut Rennke, MD
• IgA Nephropathy — Gerald Appel, MD
• Metabolic Management of Kidney Stones — Gary Curhan, MD
• AI in Nephrology: Clinical Applications — Navdeep Tangri, MD
• Faculty Q&A — Gerald Appel, MD, Gary Curhan, MD & Navdeep Tangri, MD
• Update on Lupus Nephritis — Gerald Appel, MD
• Membranous Nephropathy — Laurence Beck, MD
• Anemia Management: Update and Best Practices — Brona Moloney, MD
• Faculty Q&A — Gerald Appel, MD & Laurence Beck, MD

Self-Paced Sessions:
Glomerulonephritis: Questions & Answers Session — Gerald Appel, MD • Must-Know Clinical Images in Nephrology — Annie Liu, MD • Must-Know Board Zebras — Emily Robinson, MD • Nephrology Board Review Practice 1 — Finnian Mc Causland, MD • Nephrology Board Review Practice 2 — Gearoid McMahon, MD

Day 2 – Tuesday, August 11, 2026

• Day 2 Announcements — Course Directors
• Acid-Base Disorders I: Anion Gap Metabolic Acidosis — Alan Yu, MD
• Acid-Base Disorders II: Non-Gap Acidosis and Metabolic Alkalosis — Alan Yu, MD
• Hyponatremia and Hypernatremia — David Mount, MD
• Hypokalemia and Hyperkalemia — David Mount, MD
• Important New Trials in GN — David Mount, MD
• Genetics and Kidney Disease — Friedhelm Hildebrandt, MD
• Update on Polycystic Kidney Disease — Fouad Chebib, MD
• Faculty Q&A — David Mount, MD, Friedhelm Hildebrandt, MD & Fouad Chebib, MD
• Pediatric Nephrology — Alexis Gomez, MD
• Genetics: How to Integrate into Practice — Ana Onuchic-Whitford, MD
• Rapidly Progressive Glomerulonephritis — John Niles, MD
• Faculty Q&A — Alexis Gomez, MD, Ana Onuchic-Whitford, MD & John Niles, MD

Self-Paced Sessions:
Electrolyte and Acid Base Disorders: Questions & Answers Session – Part 1 — Alan Yu, MD • Electrolyte and Acid Base Disorders: Questions & Answers Session – Part 2 — Alan Yu, MD • Chronic Kidney Disease in the Community: Meeting Them Where They Are — Li-Li Hsiao, MD • COVID-19 Vaccine in Immunocompromised Patients — Ann Woolley, MD • Update on Renovascular Disease — Joseph Garasic, MD

Day 3 – Wednesday, August 12, 2026

• Day 3 Announcements — Course Directors
• Why Do We Reject a Transplant? — Jamil Azzi, MD
• Transplant Immunosuppression for the Boards — Kaitlyn Lei, MD
• Faculty Q&A — Jamil Azzi, MD & Kaitlyn Lei, MD
• Immunological Assessment Pre- and Post-Transplant — Melissa Yeung, MD & Indira Guleria, MD
• Early Post-Transplant Management — Anil Chandraker, MD
• Faculty Q&A — Melissa Yeung, MD & Indira Guleria, MD
• Donor Evaluation — Martina McGrath, MD
• Late Loss of the Kidney Transplant — Rania El Fekih, MD
• Infections in Transplant Recipients — Barbra Blair, MD
• Monitoring Kidney Transplant Patients: Beyond Creatinine — Jamil Azzi, MD
• Pre-Transplant Evaluation of Recipients — Rania El Fekih, MD
• Faculty Q&A — Martina McGrath, MD, Jamil Azzi, MD, Rania El Fekih, MD & Barbra Blair, MD
• Thrombotic Microangiopathies — Jean Francis, MD
• Late Post-Transplant Medical Complications — Leonardo Riella, MD
• KEYNOTE: Xenotransplantation — Leonardo Riella, MD
• Geriatric Nephrology — Ernest Mandel, MD
• Faculty Q&A — Jean Francis, MD, Ernest Mandel, MD & Leonardo Riella, MD

Self-Paced Sessions:
Pre-Transplant Surgical Evaluation of Recipients — Sayeed Malek, MD • Immunologic Basis of Kidney Disease — Vivek Kasinath, MD • Use of Checkpoint Inhibitors in Kidney Transplant Recipients — Naoka Murakami, MD • Transplant Cases: Board Review — Melissa Yeung, MD & Edgar Milford, MD • Transplant Board Review — Anil Chandraker, MD • Poisonings and Intoxications: What a Nephrologist Needs to Know — Charlotte Goldfine, MD

Day 4 – Thursday, August 13, 2026

• Day 4 Announcements — Course Directors
• Cardiorenal Syndrome — Finnian Mc Causland, MD
• Management of Hypertension in CKD-Intensive or Standard Regimens — Richard Glassock, MD
• Faculty Q&A — Richard Glassock, MD & Finnian Mc Causland, MD
• Primary Aldosteronism — Anand Vaidya, MD
• Therapy of FSGS Lesions in 2026 — Richard Glassock, MD
• Liver and the Kidney — Andrew Allegretti, MD
• Faculty Q&A — Anand Vaidya, MD, Andrew Allegretti, MD & Richard Glassock, MD
• Pathophysiology of Acute Kidney Injury — Joseph Bonventre, MD
• Acute Kidney Injury Syndromes — Alice Sheridan, MD
• ICU Nephrology and Continuous Renal Replacement Therapies — Andrew Allegretti, MD
• Faculty Q&A — Joseph Bonventre, MD, Alice Sheridan, MD & Andrew Allegretti, MD
• Cancer and Acute Kidney Injury — Abdullah Jalal, MD
• Paraprotein-Induced Kidney Injury — Raad Chowdhury, MD
• KEYNOTE: Kidney PAL Program — Samantha Gelfand, MD
• Pathophysiology and Treatment of Diabetic Kidney Disease — Gearoid McMahon, MD
• APOL1 and Kidney Disease — Opeyemi Olabisi, MD
• Faculty Q&A — Samantha Gelfand, MD, Opeyemi Olabisi, MD, Raad Chowdhury, MD & Gearoid McMahon, MD

Self-Paced Sessions:
Interstitial Nephritis — Julie Paik, MD • Ethics — Kathleen McFadden, MD • Pregnancy and Renal Disease — Jessica Tangren, MD

Day 5 – Friday, August 14, 2026

• Day 5 Announcements — Course Directors
• Patient Perspective: Dialysis Dosing — John Kevin Tucker, MD
• Hemodiafiltration — John Kevin Tucker, MD
• Mineral and Bone Disease — David Bushinsky, MD
• Faculty Q&A — David Bushinsky, MD & John Kevin Tucker, MD
• Dialysis: A Case-Based Clinical Review and Update — John Kevin Tucker, MD
• Pearls in Mineral and Bone Disease — David Bushinsky, MD
• Chronic Kidney Disease Epidemiology: A 2026 Update — Gearoid McMahon, MD
• Faculty Q&A — Gearoid McMahon, MD, David Bushinsky, MD & John Kevin Tucker, MD
• Peritoneal Dialysis — Joanne Bargman, MD
• Peritoneal Dialysis Complications — Joanne Bargman, MD
• Acute Kidney Injury Related to Immune Checkpoint Inhibitors — Shruti Gupta, MD
• Faculty Q&A — Joanne Bargman, MD & Shruti Gupta, MD
• Mesoamerican Nephropathy — David Friedman, MD
• Ultrasound for the Clinical Nephrologist — Adina Voiculescu, MD
• Dialysis Vascular Access: Assessment and Complications — Dirk Hentschel, MD
• Faculty Q&A — Adina Voiculescu, MD, Dirk Hentschel, MD & David Friedman, MD
• Closing Remarks